C4 Therapeutics' GAAP loss for 6M 2021 was $43.551 million, up 91.8% from $22.705 million in the prior year. Revenue increased 4.4% to $17.207 million from $16.486 million a year earlier.
C4 Therapeutics' GAAP loss for 6M 2021 was $43.551 million, up 91.8% from $22.705 million in the prior year. Revenue increased 4.4% to $17.207 million from $16.486 million a year earlier. 
ir.c4therapeutics.com
English (US) 